| Year |
Citation |
Score |
| 2023 |
Makowski EK, Wang T, Zupancic JM, Huang J, Wu L, Schardt JS, De Groot AS, Elkins SL, Martin WD, Tessier PM. Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning. Nature Biomedical Engineering. PMID 37666923 DOI: 10.1038/s41551-023-01074-6 |
0.359 |
|
| 2023 |
Zupancic JM, Smith MD, Trzeciakiewicz H, Skinner ME, Ferris SP, Makowski EK, Lucas MJ, McArthur N, Kane RS, Paulson HL, Tessier PM. Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates. Frontiers in Immunology. 14: 1164080. PMID 37622125 DOI: 10.3389/fimmu.2023.1164080 |
0.313 |
|
| 2023 |
Desai AA, Zupancic JM, Trzeciakiewicz H, Gerson JE, DuBois KN, Skinner ME, Sharkey LM, McArthur N, Ferris SP, Bhatt NN, Makowski EK, Smith MD, Chen H, Huang J, Jerez C, ... ... Tessier PM, et al. Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils. Biorxiv : the Preprint Server For Biology. PMID 37461643 DOI: 10.1101/2023.07.04.547698 |
0.369 |
|
| 2022 |
Makowski EK, Chen H, Lambert M, Bennett EM, Eschmann NS, Zhang Y, Zupancic JM, Desai AA, Smith MD, Lou W, Fernando A, Tully T, Gallo CJ, Lin L, Tessier PM. Reduction of therapeutic antibody self-association using yeast-display selections and machine learning. Mabs. 14: 2146629. PMID 36433737 DOI: 10.1080/19420862.2022.2146629 |
0.338 |
|
| 2022 |
Desai AA, Zupancic JM, Smith MD, Tessier PM. Isolating Anti-amyloid Antibodies from Yeast-Displayed Libraries. Methods in Molecular Biology (Clifton, N.J.). 2491: 471-490. PMID 35482203 DOI: 10.1007/978-1-0716-2285-8_22 |
0.378 |
|
| 2022 |
Gupta P, Makowski EK, Kumar S, Zhang Y, Scheer JM, Tessier PM. Antibodies with Weakly Basic Isoelectric Points Minimize Trade-offs between Formulation and Physiological Colloidal Properties. Molecular Pharmaceutics. PMID 35108018 DOI: 10.1021/acs.molpharmaceut.1c00373 |
0.377 |
|
| 2021 |
Makowski EK, Schardt JS, Tessier PM. Improving antibody drug development using bionanotechnology. Current Opinion in Biotechnology. 74: 137-145. PMID 34890875 DOI: 10.1016/j.copbio.2021.10.027 |
0.34 |
|
| 2021 |
Schardt JS, Pornnoppadol G, Desai AA, Park KS, Zupancic JM, Makowski EK, Smith MD, Chen H, Garcia de Mattos Barbosa M, Cascalho M, Lanigan TM, Moon JJ, Tessier PM. Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening. Scientific Reports. 11: 20738. PMID 34671080 DOI: 10.1038/s41598-021-99401-x |
0.314 |
|
| 2021 |
Makowski EK, Wu L, Desai AA, Tessier PM. Highly sensitive detection of antibody nonspecific interactions using flow cytometry. Mabs. 13: 1951426. PMID 34313552 DOI: 10.1080/19420862.2021.1951426 |
0.359 |
|
| 2021 |
Makowski EK, Wu L, Gupta P, Tessier PM. Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods. Mabs. 13: 1895540. PMID 34313532 DOI: 10.1080/19420862.2021.1895540 |
0.309 |
|
| 2021 |
Zupancic JM, Desai AA, Schardt JS, Pornnoppadol G, Makowski EK, Smith MD, Kennedy AA, Garcia de Mattos Barbosa M, Cascalho M, Lanigan TM, Tai AW, Tessier PM. Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis. Cell Chemical Biology. PMID 34171229 DOI: 10.1016/j.chembiol.2021.05.019 |
0.301 |
|
| 2021 |
Starr CG, Makowski EK, Wu L, Berg B, Kingsbury JS, Gokarn YR, Tessier PM. Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties. Molecular Pharmaceutics. PMID 34105965 DOI: 10.1021/acs.molpharmaceut.1c00280 |
0.38 |
|
| 2021 |
Desai AA, Smith MD, Zhang Y, Makowski EK, Gerson JE, Ionescu E, Starr CG, Zupancic JM, Moore SJ, Sutter AB, Ivanova MI, Murphy GG, Paulson HL, Tessier PM. Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity. The Journal of Biological Chemistry. 100508. PMID 33675750 DOI: 10.1016/j.jbc.2021.100508 |
0.395 |
|
| 2020 |
Lou W, Stimple SD, Desai AA, Makowski EK, Kalyoncu S, Mogensen JE, Spang LT, Asgreen DJ, Staby A, Duus K, Amstrup J, Zhang Y, Tessier PM. Directed evolution of conformation-specific antibodies for sensitive detection of polypeptide aggregates in therapeutic drug formulations. Biotechnology and Bioengineering. PMID 33095442 DOI: 10.1002/bit.27610 |
0.344 |
|
| 2020 |
Sawant MS, Streu CN, Wu L, Tessier PM. Toward Drug-Like Multispecific Antibodies by Design. International Journal of Molecular Sciences. 21. PMID 33053650 DOI: 10.3390/ijms21207496 |
0.339 |
|
| 2020 |
Stimple SD, Smith MD, Tessier PM. Directed evolution methods for overcoming trade-offs between protein activity and stability. Aiche Journal. American Institute of Chemical Engineers. 66. PMID 32719568 DOI: 10.1002/Aic.16814 |
0.385 |
|
| 2020 |
Zhang Y, Wu L, Gupta P, Desai AA, Smith MD, Rabia LA, Ludwig SD, Tessier PM. Physicochemical rules for identifying monoclonal antibodies with drug-like specificity. Molecular Pharmaceutics. PMID 32453957 DOI: 10.1021/Acs.Molpharmaceut.0C00257 |
0.462 |
|
| 2019 |
Lee CH, Kang TH, Godon O, Watanabe M, Delidakis G, Gillis CM, Sterlin D, Hardy D, Cogné M, Macdonald LE, Murphy AJ, Tu N, Lee J, McDaniel JR, Makowski E, ... Tessier PM, et al. An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence. Nature Communications. 10: 5031. PMID 31695028 DOI: 10.1038/S41467-019-13108-2 |
0.369 |
|
| 2019 |
Alam ME, Slaney TR, Wu L, Das TK, Kar S, Barnett GV, Leone A, Tessier PM. Unique impacts of methionine oxidation, tryptophan oxidation and asparagine deamidation on antibody stability and aggregation. Journal of Pharmaceutical Sciences. PMID 31678251 DOI: 10.1016/J.Xphs.2019.10.051 |
0.444 |
|
| 2019 |
Stimple SD, Kalyoncu S, Desai AA, Mogensen JE, Spang LT, Asgreen DJ, Staby A, Tessier PM. Sensitive detection of glucagon aggregation using amyloid fibril-specific antibodies. Biotechnology and Bioengineering. PMID 30982957 DOI: 10.1002/Bit.26994 |
0.443 |
|
| 2019 |
Julian MC, Rabia LA, Desai AA, Arsiwala A, Gerson JE, Paulson HL, Kane RS, Tessier PM. Nature-inspired design and evolution of anti-amyloid antibodies. The Journal of Biological Chemistry. PMID 30918024 DOI: 10.1074/Jbc.Ra118.004731 |
0.471 |
|
| 2019 |
Alam ME, Barnett GV, Slaney TR, Starr CG, Das TK, Tessier PM. Deamidation can compromise antibody colloidal stability and enhance aggregation in a pH-dependent manner. Molecular Pharmaceutics. PMID 30916563 DOI: 10.1021/Acs.Molpharmaceut.8B01311 |
0.409 |
|
| 2019 |
Starr CG, Tessier PM. Selecting and engineering monoclonal antibodies with drug-like specificity. Current Opinion in Biotechnology. 60: 119-127. PMID 30822699 DOI: 10.1016/J.Copbio.2019.01.008 |
0.442 |
|
| 2019 |
Rabia LA, Zhang Y, Ludwig SD, Julian MC, Tessier PM. Net charge of antibody complementarity-determining regions is a key predictor of specificity. Protein Engineering, Design & Selection : Peds. PMID 30770934 DOI: 10.1093/Protein/Gzz002 |
0.417 |
|
| 2018 |
Rabia LA, Desai AA, Jhajj HS, Tessier PM. Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility. Biochemical Engineering Journal. 137: 365-374. PMID 30666176 DOI: 10.1016/J.Bej.2018.06.003 |
0.419 |
|
| 2017 |
Alam ME, Geng SB, Bender C, Ludwig SD, Linden L, Hoet R, Tessier PM. Biophysical and sequence-based methods for identifying monovalent and bivalent antibodies with high colloidal stability. Molecular Pharmaceutics. PMID 29154550 DOI: 10.1021/Acs.Molpharmaceut.7B00779 |
0.48 |
|
| 2017 |
Tiller KE, Chowdhury R, Li T, Ludwig SD, Sen S, Maranas CD, Tessier PM. Facile Affinity Maturation of Antibody Variable Domains Using Natural Diversity Mutagenesis. Frontiers in Immunology. 8: 986. PMID 28928732 DOI: 10.3389/Fimmu.2017.00986 |
0.435 |
|
| 2017 |
Tiller KE, Li L, Kumar S, Julian MC, Garde S, Tessier PM. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs. The Journal of Biological Chemistry. PMID 28778924 DOI: 10.1074/Jbc.M117.783837 |
0.419 |
|
| 2017 |
Julian MC, Li L, Garde S, Wilen R, Tessier PM. Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability. Scientific Reports. 7: 45259. PMID 28349921 DOI: 10.1038/Srep45259 |
0.364 |
|
| 2016 |
Nilvebrant J, Tessier PM, Sidhu SS. Engineered autonomous human variable domains. Current Pharmaceutical Design. PMID 27655414 DOI: 10.2174/1381612822666160921143011 |
0.398 |
|
| 2016 |
Geng SB, Wu J, Alam ME, Schultz JS, Dickinson CD, Seminer CR, Tessier PM. A facile method for preparing stable antibody-gold conjugates and application to affinity-capture self-interaction nanoparticle spectroscopy. Bioconjugate Chemistry. PMID 27494306 DOI: 10.1021/Acs.Bioconjchem.6B00207 |
0.468 |
|
| 2016 |
Geng SB, Wittekind M, Vigil A, Tessier PM. Measurements of monoclonal antibody self-association are correlated with complex biophysical properties. Molecular Pharmaceutics. PMID 27045771 DOI: 10.1021/Acs.Molpharmaceut.6B00071 |
0.472 |
|
| 2015 |
Lee CC, Julian MC, Tiller KE, Meng F, DuConge SE, Akter R, Raleigh DP, Tessier PM. Design and Optimization of Anti-Amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide. The Journal of Biological Chemistry. PMID 26601942 DOI: 10.1074/Jbc.M115.682336 |
0.403 |
|
| 2015 |
Julian MC, Lee CC, Tiller KE, Rabia LA, Day EK, Schick AJ, Tessier PM. Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies. Protein Engineering, Design & Selection : Peds. PMID 26386257 DOI: 10.1093/Protein/Gzv050 |
0.429 |
|
| 2015 |
Wu J, Schultz JS, Weldon CL, Sule SV, Chai Q, Geng SB, Dickinson CD, Tessier PM. Discovery of highly soluble antibodies prior to purification using affinity-capture self-interaction nanoparticle spectroscopy. Protein Engineering, Design & Selection : Peds. PMID 26363633 DOI: 10.1093/Protein/Gzv045 |
0.498 |
|
| 2015 |
Tiller KE, Tessier PM. Advances in Antibody Design. Annual Review of Biomedical Engineering. PMID 26274600 DOI: 10.1146/Annurev-Bioeng-071114-040733 |
0.43 |
|
| 2015 |
Estep P, Caffry I, Yu Y, Sun T, Cao Y, Lynaugh H, Jain T, Vásquez M, Tessier PM, Xu Y. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies. Mabs. 7: 553-61. PMID 25790175 DOI: 10.1080/19420862.2015.1016694 |
0.487 |
|
| 2015 |
Li X, Geng SB, Chiu ML, Saro D, Tessier PM. High-throughput assay for measuring monoclonal antibody self-association and aggregation in serum. Bioconjugate Chemistry. 26: 520-8. PMID 25714504 DOI: 10.1021/Acs.Bioconjchem.5B00010 |
0.481 |
|
| 2015 |
Li X, Geng SB, Chiu ML, Saro D, Tessier PM. High-Throughput Assay for Measuring Monoclonal Antibody Self-Association and Aggregation in Serum Bioconjugate Chemistry. 26: 520-528. DOI: 10.1021/acs.bioconjchem.5b00010 |
0.352 |
|
| 2014 |
Jayaraman J, Wu J, Brunelle MC, Cruz AM, Goldberg DS, Lobo B, Shah A, Tessier PM. Plasmonic measurements of monoclonal antibody self-association using self-interaction nanoparticle spectroscopy. Biotechnology and Bioengineering. PMID 25367343 DOI: 10.1002/bit.25221 |
0.371 |
|
| 2014 |
Geng SB, Cheung JK, Narasimhan C, Shameem M, Tessier PM. Improving monoclonal antibody selection and engineering using measurements of colloidal protein interactions Journal of Pharmaceutical Sciences. 103: 3356-3363. PMID 25209466 DOI: 10.1002/Jps.24130 |
0.457 |
|
| 2014 |
Jayaraman J, Wu J, Brunelle MC, Cruz AM, Goldberg DS, Lobo B, Shah A, Tessier PM. Plasmonic measurements of monoclonal antibody self-association using self-interaction nanoparticle spectroscopy. Biotechnology and Bioengineering. 111: 1513-20. PMID 25097914 DOI: 10.1002/Bit.25221 |
0.465 |
|
| 2014 |
Liu Y, Caffry I, Wu J, Geng SB, Jain T, Sun T, Reid F, Cao Y, Estep P, Yu Y, Vaśquez M, Tessier PM, Xu Y. High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy Mabs. 6: 483-492. PMID 24492294 DOI: 10.4161/Mabs.27431 |
0.481 |
|
| 2014 |
Tessier PM, Wu J, Dickinson CD. Emerging methods for identifying monoclonal antibodies with low propensity to self-associate during the early discovery process Expert Opinion On Drug Delivery. 11: 461-465. PMID 24444112 DOI: 10.1517/17425247.2014.876989 |
0.47 |
|
| 2014 |
Perchiacca JM, Lee CC, Tessier PM. Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold. Protein Engineering, Design & Selection : Peds. 27: 29-39. PMID 24398633 DOI: 10.1093/Protein/Gzt058 |
0.392 |
|
| 2014 |
Tessier P. Antibodies by design New Biotechnology. 31: S36. DOI: 10.1016/J.Nbt.2014.05.1693 |
0.363 |
|
| 2013 |
Li X, Zhang X, Ladiwala AR, Du D, Yadav JK, Tessier PM, Wright PE, Kelly JW, Buxbaum JN. Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19423-33. PMID 24336709 DOI: 10.1523/Jneurosci.2561-13.2013 |
0.34 |
|
| 2013 |
Andersson EK, Bengtsson C, Evans ML, Chorell E, Sellstedt M, Lindgren AE, Hufnagel DA, Bhattacharya M, Tessier PM, Wittung-Stafshede P, Almqvist F, Chapman MR. Modulation of curli assembly and pellicle biofilm formation by chemical and protein chaperones. Chemistry & Biology. 20: 1245-54. PMID 24035282 DOI: 10.1016/J.Chembiol.2013.07.017 |
0.309 |
|
| 2013 |
Lee CC, Perchiacca JM, Tessier PM. Toward aggregation-resistant antibodies by design Trends in Biotechnology. 31: 612-620. PMID 23932102 DOI: 10.1016/J.Tibtech.2013.07.002 |
0.45 |
|
| 2013 |
Sule SV, Dickinson CD, Lu J, Chow CK, Tessier PM. Rapid analysis of antibody self-association in complex mixtures using immunogold conjugates Molecular Pharmaceutics. 10: 1322-1331. PMID 23383873 DOI: 10.1021/Mp300524X |
0.486 |
|
| 2012 |
Ladiwala AR, Bhattacharya M, Perchiacca JM, Cao P, Raleigh DP, Abedini A, Schmidt AM, Varkey J, Langen R, Tessier PM. Rational design of potent domain antibody inhibitors of amyloid fibril assembly. Proceedings of the National Academy of Sciences of the United States of America. 109: 19965-70. PMID 23161913 DOI: 10.1073/Pnas.1208797109 |
0.465 |
|
| 2012 |
Perchiacca JM, Ladiwala AR, Bhattacharya M, Tessier PM. Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions. Protein Engineering, Design & Selection : Peds. 25: 591-601. PMID 22843678 DOI: 10.1093/Protein/Gzs042 |
0.443 |
|
| 2012 |
Ladiwala AR, Litt J, Kane RS, Aucoin DS, Smith SO, Ranjan S, Davis J, Van Nostrand WE, Tessier PM. Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity. The Journal of Biological Chemistry. 287: 24765-73. PMID 22547072 DOI: 10.1074/Jbc.M111.329763 |
0.347 |
|
| 2012 |
Perchiacca JM, Tessier PM. Engineering aggregation-resistant antibodies. Annual Review of Chemical and Biomolecular Engineering. 3: 263-86. PMID 22468604 DOI: 10.1146/Annurev-Chembioeng-062011-081052 |
0.468 |
|
| 2012 |
Ladiwala AR, Perchiacca JM, Fishman ZS, Bhattacharya M, Hickey AM, Domigan BG, Dordick JS, Tessier PM. Polyphenolic disaccharides endow proteins with unusual resistance to aggregation. Biotechnology and Bioengineering. 109: 1869-74. PMID 22331747 DOI: 10.1002/Bit.24460 |
0.366 |
|
| 2012 |
Sule SV, Cheung JK, Antochshuk V, Bhalla AS, Narasimhan C, Blaisdell S, Shameem M, Tessier PM. Solution pH that minimizes self-association of three monoclonal antibodies is strongly dependent on ionic strength. Molecular Pharmaceutics. 9: 744-51. PMID 22221144 DOI: 10.1021/Mp200448J |
0.445 |
|
| 2012 |
Perchiacca JM, Ladiwala AR, Bhattacharya M, Tessier PM. Structure-based design of conformation- and sequence-specific antibodies against amyloid β. Proceedings of the National Academy of Sciences of the United States of America. 109: 84-9. PMID 22171009 DOI: 10.1073/Pnas.1111232108 |
0.471 |
|
| 2012 |
Posada D, Tessier PM, Hirsa AH. Removal versus fragmentation of amyloid-forming precursors via membrane filtration. Biotechnology and Bioengineering. 109: 840-5. PMID 22012557 DOI: 10.1002/Bit.24341 |
0.313 |
|
| 2011 |
Sule SV, Sukumar M, Weiss IV WF, Marcelino-Cruz AM, Sample T, Tessier PM. High-throughput analysis of concentration-dependent antibody self-association Biophysical Journal. 101: 1749-1757. PMID 21961601 DOI: 10.1016/J.Bpj.2011.08.036 |
0.466 |
|
| 2011 |
Perchiacca JM, Bhattacharya M, Tessier PM. Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions Proteins: Structure, Function and Bioinformatics. 79: 2637-2647. PMID 21732420 DOI: 10.1002/Prot.23085 |
0.466 |
|
| 2011 |
Ladiwala ARA, Mora-Pale M, Lin JC, Bale SS, Fishman ZS, Dordick JS, Tessier PM. Polyphenolic Glycosides and Aglycones Utilize Opposing Pathways To Selectively Remodel and Inactivate Toxic Oligomers of Amyloid β Chembiochem. 12: 1749-1758. PMID 21671331 DOI: 10.1002/Cbic.201100123 |
0.318 |
|
| 2011 |
Ladiwala AR, Dordick JS, Tessier PM. Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways. The Journal of Biological Chemistry. 286: 3209-18. PMID 21098486 DOI: 10.1074/Jbc.M110.173856 |
0.322 |
|
| 2010 |
Ladiwala ARA, Lin JC, Bale SS, Marcelino-Cruz AM, Bhattacharya M, Dordick JS, Tessier PM. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Aβ into off-pathway conformers Journal of Biological Chemistry. 285: 24228-24237. PMID 20511235 DOI: 10.1074/Jbc.M110.133108 |
0.358 |
|
| 2009 |
Tessier PM, Lindquist S. Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+]. Nature Structural & Molecular Biology. 16: 598-605. PMID 19491937 DOI: 10.1038/Nsmb.1617 |
0.326 |
|
| 2009 |
Bengali AN, Tessier PM. Biospecific protein immobilization for rapid analysis of weak protein interactions using self-interaction nanoparticle spectroscopy. Biotechnology and Bioengineering. 104: 240-50. PMID 19489026 DOI: 10.1002/Bit.22392 |
0.424 |
|
| 2008 |
Tessier PM, Jinkoji J, Cheng YC, Prentice JL, Lenhoff AM. Self-interaction nanoparticle spectroscopy: a nanoparticle-based protein interaction assay. Journal of the American Chemical Society. 130: 3106-12. PMID 18271584 DOI: 10.1021/Ja077624Q |
0.59 |
|
| 2004 |
Tessier PM, Verruto VJ, Sandler SI, Lenhoff AM. Correlation of diafiltration sieving behavior of lysozyme-BSA mixtures with osmotic second virial cross-coefficients. Biotechnology and Bioengineering. 87: 303-10. PMID 15281105 DOI: 10.1002/Bit.20115 |
0.528 |
|
| 2004 |
Tessier PM, Sandler SI, Lenhoff AM. Direct measurement of protein osmotic second virial cross coefficients by cross-interaction chromatography. Protein Science : a Publication of the Protein Society. 13: 1379-90. PMID 15075404 DOI: 10.1110/Ps.03419204 |
0.542 |
|
| 2003 |
Tessier PM, Lenhoff AM. Measurements of protein self-association as a guide to crystallization. Current Opinion in Biotechnology. 14: 512-6. PMID 14580581 DOI: 10.1016/S0958-1669(03)00114-9 |
0.408 |
|
| 2003 |
Tessier PM, Johnson HR, Pazhianur R, Berger BW, Prentice JL, Bahnson BJ, Sandler SI, Lenhoff AM. Predictive crystallization of ribonuclease A via rapid screening of osmotic second virial coefficients. Proteins. 50: 303-11. PMID 12486724 DOI: 10.1002/Prot.10249 |
0.509 |
|
| 2002 |
Tessier PM, Vandrey SD, Berger BW, Pazhianur R, Sandler SI, Lenhoff AM. Self-interaction chromatography: a novel screening method for rational protein crystallization. Acta Crystallographica. Section D, Biological Crystallography. 58: 1531-5. PMID 12351855 DOI: 10.1107/S0907444902012775 |
0.531 |
|
| 2002 |
Tessier PM, Lenhoff AM, Sandler SI. Rapid measurement of protein osmotic second virial coefficients by self-interaction chromatography. Biophysical Journal. 82: 1620-31. PMID 11867474 DOI: 10.1016/S0006-3495(02)75513-6 |
0.548 |
|
| Show low-probability matches. |